市场调查报告书
商品编码
1291590
空心胶囊市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球空胶囊市场规模达到28亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到45亿美元,在2023-2028年期间呈现7.5%的增长率(CAGR)。
空胶囊指的是封装药物的稳定外壳,以各种剂型在病人体内给药,如颗粒剂和丸剂。它们在商业上有两种不同的类型,明胶和非明胶。明胶胶囊(硬的和软的)是一种高胶原蛋白的动物性药品,由猪肉和牛肉及鸡肉结缔组织制造。另一方面,非明胶或素食胶囊是由淀粉和羟丙基甲基纤维素(HPMC)混合生产的。目前,空胶囊在保健和治疗方面有广泛的应用。
心血管疾病和慢性病发病率的增加以及老年人口的增加是推动空胶囊市场增长的一些关键因素。与此相呼应,为确保那些没有接受胶囊药物治疗的患者的胃肠道安全而推出的胶囊中的胶囊技术是另一个促进增长的因素。此外,制造商对生产各种医药产品(如抗菌剂、抗酸剂、吸入剂、膳食补充剂、止痛剂和抗生素)的速释胶囊的需求不断上升,也促进了市场的增长。医疗保健行业的迅速扩张和非胶质胶囊的广泛采用,如羟丙基甲基纤维素(HPMC),由于其适度的强度、透明度和抗油和脂肪的特性,正在推动市场增长。此外,医疗部门为引进创新疗法和药物而进行的研究和开发(R&D)活动的投资增加,也积极刺激了市场的增长。其他因素,如容易获得先进的治疗方案,空胶囊供应商和明胶制造商之间的战略合作,以及对各种膳食补充剂、免疫增强剂和药物的需求增长,都为市场创造了积极的前景。
The global empty capsules market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient's body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global empty capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.
Gelatin Capsule
Non-gelatin Capsule
Pig Meat
Bovine Meat
Bone
Hydroxypropyl Methylcellulose (HPMC)
Others
Immediate-release Capsules
Sustained-release Capsules
Delayed-release Capsules
Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Cardiovascular Therapy Drugs
Others
Pharmaceutical Industry
Nutraceutical Industry
Cosmetics Industry
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
Key Questions Answered in This Report
1. What was the size of the global empty capsules market in 2022?
2. What is the expected growth rate of the global empty capsules market during 2023-2028?
3. What are the key factors driving the global empty capsules market?
4. What has been the impact of COVID-19 on the global empty capsules market?
5. What is the breakup of the global empty capsules market based on the type?
6. What is the breakup of the global empty capsules market based on the raw material?
7. What is the breakup of the global empty capsules market based on the functionality?
8. What is the breakup of the global empty capsules market based on the end user?
9. What are the key regions in the global empty capsules market?
10. Who are the key players/companies in the global empty capsules market?